Table 2.
Top 15 Journals and co-cited journals on research of ncRNAs in OS research.
| Rank | Journal | Count(%) | IF (2022) | JCR | Co-Cited Journal | Co-Citation | IF (2022) | JCR |
|---|---|---|---|---|---|---|---|---|
| 1 | Oncology Letters | 139 (3.82%) | 2.9 | Q3 | Oncotarget | 4,268 | / | / |
| 2 | European Review for Medical and Pharmacological Sciences | 120 (3.31%) | 3.3 | Q2 | Cancer Research | 3,500 | 11.2 | Q1 |
| 3 | Molecular Medicine Reports | 95 (2.61%) | 3.4 | Q3 | Plos One | 3,378 | 3.7 | Q2 |
| 4 | Oncotargets and Therapy | 82 (2.25%) | 4.0 | Q2 | Cell | 2,793 | 64.5 | Q1 |
| 5 | Biochemical and Biophysical Research Communications | 81 (2.22%) | 3.1 | Q2 | Oncogene | 2,737 | 8.0 | Q1 |
| 6 | Oncotarget | 81 (2.22%) | / | / | Biochemical and Biophysical Research Communications | 2,712 | 3.1 | Q2 |
| 7 | Biomedicine & Pharmacotherapy | 74 (2.03%) | 7.5 | Q1 | Tumor Biology | 2,410 | / | / |
| 8 | Oncology Reports | 73 (2.00%) | 4.2 | Q2 | Nature | 2,244 | 64.8 | Q1 |
| 9 | Tumor Biology | 69 (1.89%) | / | / | Cancer Letters | 2,043 | 9.7 | Q1 |
| 10 | Frontiers in Oncology | 65 (1.78%) | 4.7 | Q2 | Molecular Cancer | 2,040 | 37.3 | Q1 |
| 11 | International Journal of Clinical and Experimental Pathology | 63 (1.73%) | / | / | Journal of Biological Chemistry | 2,035 | 4.8 | Q2 |
| 12 | Journal of Cellular Biochemistry | 57 (1.57%) | 4.0 | Q2 | Oncology Letters | 1,823 | 2.9 | Q4 |
| 13 | Cancer Cell International | 55 (1.51%) | 5.8 | Q1 | Oncology Reports | 1,801 | 4.2 | Q2 |
| 14 | Plos One | 54 (1.48%) | 3.7 | Q2 | Biomedicine & Pharmacotherapy | 1,788 | 7.5 | Q1 |
| 15 | Experimental and Therapeutic Medicine | 52 (1.43%) | 2.7 | Q3 | Proceedings of the National Academy of Sciences of The United States Of America | 1,774 | 11.1 | Q1 |